Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maximilian Merz

Showing results (31-40 of 127) with videos related to

Pageof 13
Sort By:
Cancers|May 28, 2020
Can <sup>18</sup>F-NaF PET/CT before Autologous Stem Cell Transplantation Predict Survival in Multiple Myeloma?Christos Sachpekidis, Annette Kopp-Schneider, Maximilian Merz, et al.
Neurochemical Research|July 17, 2016
Genetic Susceptibility to Bortezomib-Induced Peripheral Neuroropathy: Replication of the Reported Candidate Susceptibility LociChiara Campo, Miguel Inacio Da Silva Filho, Niels Weinhold, et al.
The Plant Journal : for Cell and Molecular Biology|May 25, 2019
Glucosylation of the phytoalexin N-feruloyl tyramine modulates the levels of pathogen-responsive metabolites in Nicotiana benthamianaGuangxin Sun, Michael Strebl, Maximilian Merz, et al.
Bioinformatics (Oxford, England)|February 25, 2026
CERTOMICS: Trusted Single-Cell Multiomics Pipeline for High-Resolution Profiling of Adoptive Cellular ImmunotherapiesChristina Katharina Kuhn, David Schmidt, Michael Rade, et al.
Oncology|October 3, 2024
Efficacy and Safety of Autologous Stem Cell Transplantation in First-Line Treatment and at Relapse in Elderly Patients with Multiple MyelomaEva-Maria Klein, Sejla Hujic, Kaya Miah, et al.
Leukemia|July 7, 2018
Cytogenetic abnormalities in monoclonal gammopathy of undetermined significanceMaximilian Merz, Thomas Hielscher, Korbinian Hoffmann, et al.
American Journal of Hematology|August 11, 2016
Baseline characteristics, chromosomal alterations, and treatment affecting prognosis of deletion 17p in newly diagnosed myelomaMaximilian Merz, Thomas Hielscher, Anja Seckinger, et al.
Hematological Oncology|March 21, 2017
Bortezomib-induced peripheral neuropathy: A genome-wide association study on multiple myeloma patientsChiara Campo, Miguel Inacio da Silva Filho, Niels Weinhold, et al.
Genome Biology|December 15, 2023
A time-resolved meta-analysis of consensus gene expression profiles during human T-cell activationMichael Rade, Sebastian Böhlen, Vanessa Neuhaus, et al.
Haematologica|March 11, 2017
Survival of patients with lymphoplasmacytic lymphoma and solitary plasmacytoma in Germany and the United States of America in the early 21<sup>st</sup> centuryJanick Weberpals, Dianne Pulte, Lina Jansen, et al.
Pageof 13

Showing results (31-40 of 127) with videos related to

Sort By:
Pageof 13
Cancers|May 28, 2020
Can <sup>18</sup>F-NaF PET/CT before Autologous Stem Cell Transplantation Predict Survival in Multiple Myeloma?Christos Sachpekidis, Annette Kopp-Schneider, Maximilian Merz, et al.
Neurochemical Research|July 17, 2016
Genetic Susceptibility to Bortezomib-Induced Peripheral Neuroropathy: Replication of the Reported Candidate Susceptibility LociChiara Campo, Miguel Inacio Da Silva Filho, Niels Weinhold, et al.
The Plant Journal : for Cell and Molecular Biology|May 25, 2019
Glucosylation of the phytoalexin N-feruloyl tyramine modulates the levels of pathogen-responsive metabolites in Nicotiana benthamianaGuangxin Sun, Michael Strebl, Maximilian Merz, et al.
Bioinformatics (Oxford, England)|February 25, 2026
CERTOMICS: Trusted Single-Cell Multiomics Pipeline for High-Resolution Profiling of Adoptive Cellular ImmunotherapiesChristina Katharina Kuhn, David Schmidt, Michael Rade, et al.
Oncology|October 3, 2024
Efficacy and Safety of Autologous Stem Cell Transplantation in First-Line Treatment and at Relapse in Elderly Patients with Multiple MyelomaEva-Maria Klein, Sejla Hujic, Kaya Miah, et al.
Leukemia|July 7, 2018
Cytogenetic abnormalities in monoclonal gammopathy of undetermined significanceMaximilian Merz, Thomas Hielscher, Korbinian Hoffmann, et al.
American Journal of Hematology|August 11, 2016
Baseline characteristics, chromosomal alterations, and treatment affecting prognosis of deletion 17p in newly diagnosed myelomaMaximilian Merz, Thomas Hielscher, Anja Seckinger, et al.
Hematological Oncology|March 21, 2017
Bortezomib-induced peripheral neuropathy: A genome-wide association study on multiple myeloma patientsChiara Campo, Miguel Inacio da Silva Filho, Niels Weinhold, et al.
Genome Biology|December 15, 2023
A time-resolved meta-analysis of consensus gene expression profiles during human T-cell activationMichael Rade, Sebastian Böhlen, Vanessa Neuhaus, et al.
Haematologica|March 11, 2017
Survival of patients with lymphoplasmacytic lymphoma and solitary plasmacytoma in Germany and the United States of America in the early 21<sup>st</sup> centuryJanick Weberpals, Dianne Pulte, Lina Jansen, et al.
Pageof 13